17: Rethinking Breast Cancer Screening with Omid Moghadam
The Startup Junkies Podcast libsyn.com
This is what was read here when it was published. Startup Junkie no longer carries it in what it publishes now.
Omid started as an electrical engineer and is now CEO of Ascendant Dx, a proteomics company focused on bringing new diagnostic tests to market. Currently they are focusing on tests based on newly discovered biomarkers for breast cancer and childhood diseases.
Omid is an experienced executive, entrepreneur and inventor. He has spent the last 18 years bringing new products and businesses to market in fields ranging from photography, medical imaging, and microprocessors to graphics, healthcare information technology and genomics.
More ways to use this
Open on another device
Scan to open this page. Your saved notes and account access are not included.